News
Final OS results from INAVO120 show inavolisib plus palbociclib and fulvestrant significantly improves survival, delays ...
The best Wi-Fi multimedia projectors bring big screen fun anywhere. Our top 10 picks deliver sharp images and easy wireless ...
Pivotal Phase 3 VERITAC-2 clinical trial results presented at ASCO demonstrate 2.9-month improvement in median progression-free survival when compared to fulvestrant in second line-plus patients with ...
Two studies reveal promising treatments for breast cancer, enhancing options for patients with triple-negative breast cancer ...
Among patients with ESR1-mutant, ER+, HER2– advanced breast cancer, vepdegestrant improved survival without progression when ...
A phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...
The Samsung Galaxy S25 Edge is impressive to look at, but doesn't seem to add up to more than the sum of its parts.
Most people keep their laptops longer than phones, so it pays to take care of them. Here are 12 simple ways to keep yours ...
Uncover the top trending cryptos on Solana Chain today as ViralMind, OX, and Yaku lead the charge with strong momentum and ...
Explore Google Messages Feature rolling out in May 2025, including enhanced RCS support for a smarter, more secure messaging ...
The 1win betting site provides a person with a range of possibilities if you’re interested in cricket. If you might have neglected your password, an individual should use the particular security ...
NEW YORK, NY, USA I May 30, 2025 I Pfizer Inc. (NYSE: PFE) today announced statistically significant and clinically meaningful survival results from the Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results